Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 41OTHER_GOV 4NIH 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 172Breast Neoplasms 102Prostatic Neoplasms 45Lung Neoplasms 42Lymphoma 37Leukemia 35Brain Neoplasms 35Melanoma 29Ovarian Neoplasms 24Lymphoma, Non-Hodgkin 20Stomach Neoplasms 18HIV Infections 17Colonic Neoplasms 17Esophageal Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Urinary Bladder Neoplasms 15Glioma 15Acquired Immunodeficiency Syndrome 15Sarcoma, Kaposi 14Neoplasm Metastasis 14Leukemia, Myeloid, Acute 14Thyroid Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Kidney Neoplasms 13Hematologic Neoplasms 13Endometrial Neoplasms 13Colorectal Neoplasms 13Uterine Cervical Neoplasms 12Sarcoma 12Neurofibromatosis 1 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Observational × Insulin Resistance × Clear all
NCT01143480 2026-06-01

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

National Institutes of Health Clinical Center (CC)

Recruiting
725 enrolled

Asthma, Insulin Resistance, Neoplasms, Metabolic Syndrome, Atherosclerosis

NCT00304941 2017-07-02

Insulin Resistance and Breast Cancer

National Institutes of Health Clinical Center (CC)

Completed
25 enrolled
Breast

Breast Neoplasms, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡